Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CTSK | P43235 | 3/20 | 0.46 |
| ▸ | CTSL | P07711 | 2/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | CTSS | P25774 | 1/20 | 0.46 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.44 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.44 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.44 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.44 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.44 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19618687 | 1.00 | CA1 (0.55) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL10724727 | 1.00 | CA1 (0.55) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL741043 | 1.00 | CA1 (0.55) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL10724721 | 1.00 | CA1 (0.55) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL8446912 | 0.88 | CA1 (0.53) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL14385267 | 0.88 | CA1 (0.53) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL13078313 | 0.88 | CA1 (0.53) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL5496417 | 0.87 | CA1 (0.48) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL3893779 | 0.86 | CA1 (0.46) | CA1CA2CA7CTSKCTSL | |
| SCHEMBL7320189 | 0.86 | CA1 (0.57) | CA1CA2CA7CTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1529777-B1 | Process and oxazolidine intermediate for the synthesis of taxanes | INDENA SPA (IT) | 2007-01-03 | — | — | EP | claimed |
| US-10639293-B2 | 9,10-α,α-OH-taxane analogs and methods for production thereof | TAPESTRY PHARMACEUTICALS, INC. (US) | 2020-05-05 | — | — | US | disclosed |
| US-10238621-B2 | 9,10-α,α-OH-taxane analogs and methods for production thereof | TAPESTRY PHARMACEUTICALS, INC. (US) | 2019-03-26 | — | — | US | disclosed |
| US-20180125811-A1 | 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof | TAPESTRY PHARMACEUTICALS, INC. | 2018-05-10 | — | — | US | disclosed |
| US-20180125811-A1 | 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof | TAPESTRY PHARMACEUTICALS, INC. | 2018-05-10 | — | — | US | disclosed |
| US-9820962-B2 | 9, 10-α, α-oh-taxane analogs and methods for production thereof | TAPESTRY PHARMACEUTICALS, INC. (US) | 2017-11-21 | — | — | US | disclosed |
| EP-1529777-B1 | Process and oxazolidine intermediate for the synthesis of taxanes | INDENA SPA (IT) | 2007-01-03 | — | — | EP | disclosed |
| EP-1529777-A2 | Process and oxazolidine intermediate for the synthesis of taxanes | INDENA S.p.A. (IT) | 2005-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10238621-B2 | 9,10-α,α-OH-taxane analogs and methods for production thereof | TECR, AKR1C3, ADCY9 | CA1 855/4885CA2 2237/4885CA7 90/4885 |
| US-20180125811-A1 | 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof | TECR, ADCY9, AKR1C3 | CA1 751/4885CA2 2222/4885CA7 103/4885 |
| US-10639293-B2 | 9,10-α,α-OH-taxane analogs and methods for production thereof | TECR, AKR1C3, ADCY9 | CA1 829/4885CA2 1887/4885CA7 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.